Metastatic Liver Cancer Patient Registry Study
Part of Cancer, Digestive system clinical trials.
This study collects health information from patients with cancer that has spread to the liver. Researchers will track your medical history and outcomes to better understand how metastatic liver cancer develops and progresses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer must have spread to the liver (confirmed by biopsy or imaging)
- You must be 18 years or older
- You must be able to understand and sign an informed consent form
- Your complete medical records and baseline health data must be available
- You cannot have primary liver cancer (cancer that started in the liver)
- You cannot currently be enrolled in other interventional clinical trials
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a database of people with liver cancer (including hepatocellular carcinoma and other types). It aims to collect health information and samples over time to better understand the disease and improve future care. If you join, you will be asked to provide blood and leftover tissue from surgery or biopsy, and to follow up with the research team.
This study follows patients with stomach cancer that has spread to the liver to learn more about their health over time. It may help doctors understand how to better care for people with this condition.
This study looks at how breast cancer that has spread to the liver responds to different treatments, including surgery and medicines. The goal is to learn which approach works best for patients with this condition.
This study looks at people who have cancer that started elsewhere in the body and spread to the liver, and who are having surgery to remove the liver tumors. The goal is to learn more about their outcomes and recovery after this type of surgery.
This trial studies patients with liver cancer, including both the common type (hepatocellular carcinoma) and other types. It aims to understand the cancer better by collecting blood samples and medical information.
This study is a registry that collects information from people with cancer that has spread who are receiving radiation therapy as part of their usual care. By joining, you help researchers learn more about how radiation works in this setting.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.